Ancestry-based pharmacogenomics, adverse reactions and carbamazepine: is the FDA warning correct?

Title
Ancestry-based pharmacogenomics, adverse reactions and carbamazepine: is the FDA warning correct?
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume 14, Issue 5, Pages 473-480
Publisher
Springer Nature
Online
2014-04-22
DOI
10.1038/tpj.2014.14

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started